Drug
Indapamide Perindopril 2
Indapamide Perindopril 2: highest development phase Post-Market, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Indapamide SR 1.5mg; Perindopril 2-4mg NCT00122811 | Post-Market | Hypertension |
Latest
No recent events.
Follow Indapamide Perindopril 2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.